Nishinosono T, Muramatsu H, Wakamatsu M, Yamashita D, Fukasawa T, Shirakawa Y
J Clin Immunol. 2025; 45(1):78.
PMID: 39998705
PMC: 11861002.
DOI: 10.1007/s10875-025-01872-4.
Satitsuksanoa P, Veen W, Tan G, Lopez J, Wirz O, Jansen K
Allergy. 2024; 80(1):161-180.
PMID: 38989779
PMC: 11724240.
DOI: 10.1111/all.16220.
Masle-Farquhar E, Jeelall Y, White J, Bier J, Deenick E, Brink R
Front Immunol. 2023; 14:1095257.
PMID: 36960072
PMC: 10028194.
DOI: 10.3389/fimmu.2023.1095257.
Kameda T, Shide K, Kamiunten A, Kogure Y, Morishita D, Koya J
Commun Biol. 2022; 5(1):1309.
PMID: 36446869
PMC: 9709164.
DOI: 10.1038/s42003-022-04284-x.
Urdinez L, Erra L, Palma A, Mercogliano M, Fernandez J, Prieto E
Front Immunol. 2022; 13:1020927.
PMID: 36405754
PMC: 9668901.
DOI: 10.3389/fimmu.2022.1020927.
A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.
Zhao P, Hu Y, Sun D, Meng Q, Zhang L, Zhang X
Front Immunol. 2022; 13:943027.
PMID: 36203613
PMC: 9530255.
DOI: 10.3389/fimmu.2022.943027.
Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.
Bedsaul J, Shah N, Hutcherson S, Pomerantz J
iScience. 2022; 25(2):103810.
PMID: 35198875
PMC: 8844825.
DOI: 10.1016/j.isci.2022.103810.
Monogenic Adult-Onset Inborn Errors of Immunity.
Staels F, Collignon T, Betrains A, Gerbaux M, Willemsen M, Humblet-Baron S
Front Immunol. 2021; 12:753978.
PMID: 34867986
PMC: 8635491.
DOI: 10.3389/fimmu.2021.753978.
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.
Balasubramanian S, Hodkinson B, Schuster S, Fowler N, Trotman J, Hess G
Cancer Med. 2021; 11(1):61-73.
PMID: 34791836
PMC: 8704158.
DOI: 10.1002/cam4.4422.
Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.
Zhao P, Meng Q, Huang Y, Zhang L, Luo S, Zhang X
Front Immunol. 2021; 12:676386.
PMID: 34557185
PMC: 8453161.
DOI: 10.3389/fimmu.2021.676386.
NF-κB: At the Borders of Autoimmunity and Inflammation.
Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R
Front Immunol. 2021; 12:716469.
PMID: 34434197
PMC: 8381650.
DOI: 10.3389/fimmu.2021.716469.
.
Hutcherson S, Bedsaul J, Pomerantz J
J Immunol. 2021; 207(4):1150-1164.
PMID: 34341167
PMC: 8355193.
DOI: 10.4049/jimmunol.2001233.
Inborn errors of immunity with atopic phenotypes: A practical guide for allergists.
Castagnoli R, Lougaris V, Giardino G, Volpi S, Leonardi L, La Torre F
World Allergy Organ J. 2021; 14(2):100513.
PMID: 33717395
PMC: 7907539.
DOI: 10.1016/j.waojou.2021.100513.
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.
Yu H, Lin L, Zhang Z, Zhang H, Hu H
Signal Transduct Target Ther. 2020; 5(1):209.
PMID: 32958760
PMC: 7506548.
DOI: 10.1038/s41392-020-00312-6.
A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.
Shields A, Bauman B, Hargreaves C, Pollard A, Snow A, Patel S
J Clin Immunol. 2020; 40(2):406-411.
PMID: 31897776
DOI: 10.1007/s10875-019-00729-x.
MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A, Skordos I, Driege Y, Kreike M, Hochepied T, Baens M
Front Immunol. 2019; 10:1898.
PMID: 31474984
PMC: 6702287.
DOI: 10.3389/fimmu.2019.01898.
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.
Wang Z, Hutcherson S, Yang C, Jattani R, Tritapoe J, Yang Y
J Biol Chem. 2019; 294(40):14648-14660.
PMID: 31391255
PMC: 6779434.
DOI: 10.1074/jbc.RA119.009551.
Rare copy number variants in the genome of Chinese female children and adolescents with Turner syndrome.
Li L, Li Q, Wang Q, Liu L, Li R, Liu H
Biosci Rep. 2018; 39(1).
PMID: 30530863
PMC: 6328875.
DOI: 10.1042/BSR20181305.
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.
Bedsaul J, Carter N, Deibel K, Hutcherson S, Jones T, Wang Z
Front Immunol. 2018; 9:2105.
PMID: 30283447
PMC: 6156143.
DOI: 10.3389/fimmu.2018.02105.
The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
Lu H, Bauman B, Arjunaraja S, Dorjbal B, Milner J, Snow A
Front Immunol. 2018; 9:2078.
PMID: 30283440
PMC: 6156466.
DOI: 10.3389/fimmu.2018.02078.